Berbec, Nicoleta Mariana
Stanculeanu, Dana Lucia
Badelita, Nicoleta Sorina
Vasilica, Mariana
Popovici, Dorel Ionel
Colita, Andrei
Neacsu, Cristina
Iordan, Alexandru
Funding for this research was provided by:
Amgen Romania
Article History
Received: 13 October 2017
Accepted: 6 February 2018
First Online: 2 March 2018
Conflict of interest
: N.M. Berbec has received consulting fees from Amgen. D.L. Stanculeanu has received consulting fees from Amgen, Janssen, and Roche and is a member of the speakers bureau of Amgen, Roche, Merck, Novartis, Astellas, Janssen, Bristol-Myers Squibb, and Astra-Zeneca. N.S. Badelita received consulting fees from Amgen and is a member of the speakers bureau of Amgen. A. Colita received speakers fees from Amgen. C. Neacsu and A. Iordan are employees of Amgen and hold Amgen stock. M. Vasilica and D.I. Popovici declare that they have no competing interests.